🇺🇸 FDA
Pipeline program

Tcrx T cell

KSH02-TCRXT-CJ

Phase 1 mab active

Quick answer

Tcrx T cell for Gastric Cancer is a Phase 1 program (mab) at TScan Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
TScan Therapeutics
Indication
Gastric Cancer
Phase
Phase 1
Modality
mab
Status
active

Clinical trials